Follow The Filings

VREX Varex Imaging

Varex Imaging earnings company data as of 4:49 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 17 Nov EPS 0.33 — —
Rev — — —

Insider trades

Open-market buys and sales by VREX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VREX insider trades
  • None no insider bought on the open market
  • $200K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Jay K. Kunkel Director
    Sale
    $150K 8,121 shares at $18.48 35% of stake
    Traded Sep 14 Filed Sep 15
  2. Jay K. Kunkel Director
    Sale
    $50K 4,510 shares at $11.14 16% of stake
    Traded Mar 20 Filed Mar 23

Also filed in the last 12 months, not counted as buying or selling: 17 option exercises, 6 share withholdings for taxes, and 1 sale to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
DEFA14A
8-K 8.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
DEFA14A DEFA14A - VAREX CUSTOMER TALKING POINTS FAQ
8-K 2.02,9.01
8-K 1.01,5.02,7.01,9.01
DEFA14A
10-Q
DEFA14A DEFA14A - LETTER TO SUPPLIERS
DEFA14A DEFA14A - LETTER TO CUSTOMERS
DEFA14A DEFA14A - ANNOUNCEMENTS TO EMPLOYEES
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
8-K 1.01,1.02,2.03,8.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
DEF 14A FORM DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.